A public health driven and end-to-end approach to innovation that enables sustainable access to effective antibiotics in low- and middle-income countries is broadly supported. Learn more about the whys and hows.
While the world is caught up in responding to the COVID-19 pandemic, it has gone largely unnoticed that more than thirty years has passed since the last class of antibiotics was discovered. Meanwhile global consumption of antibiotics continues to increase. In response, bacteria have developed resistance and are spreading as a silent but steady pandemic threatening to devastate healthcare and modern medicine as we know it. Read more about the release of the report and download full report.